| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.068 | 0.2 |